Welcome to our dedicated page for Avepoint SEC filings (Ticker: AVPT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The AvePoint, Inc. (AVPT) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures, including current reports on Form 8-K and other key documents filed with the U.S. Securities and Exchange Commission. These filings offer detailed information about AvePoint’s financial results, capital markets activity, and material corporate events related to its role as a provider of data security, governance, and resilience solutions for SaaS and cloud collaboration platforms.
Investors can use AvePoint’s 8-K filings to review press releases that are furnished as exhibits, such as quarterly financial results and announcements about underwriting agreements and public offerings connected to the company’s listing on the Singapore Exchange. For example, AvePoint has filed Form 8-K reports to furnish its second and third quarter financial results and to disclose the underwriting agreement and offering terms associated with its SGX listing. These documents complement the company’s annual and quarterly reports on Forms 10-K and 10-Q, which contain broader discussions of financial condition, risk factors, and business operations.
The filings page also reflects corporate actions related to listing status. A Form 25 filing, for instance, documents the removal from listing and registration on Nasdaq of a class of AvePoint warrants under Section 12(b) of the Securities Exchange Act of 1934. Such filings help investors understand changes in how specific AvePoint securities trade and are registered.
On Stock Titan, AvePoint filings are paired with AI-powered summaries that explain the significance of each document in clear language. Users can quickly see the main points of earnings-related 8-Ks, offerings, and listing changes, while still having direct access to the full text on EDGAR. This combination of real-time updates, insider-relevant forms such as 8-K and 25, and AI-generated insights helps investors and analysts follow AvePoint’s regulatory history and ongoing disclosure practices more efficiently.
AvePoint insider sale of 500,000 shares to support SGX secondary listing. Brian Michael Brown, who serves as Chief Legal Officer and a Director, sold 500,000 shares of AvePoint common stock on 09/18/2025 at $15.21 per share as part of the company’s secondary listing on the Singapore Exchange to facilitate initial liquidity. The filing states no shares were sold on NASDAQ and the transaction was executed in accordance with Rule 144 and company insider trading policies. After the sale the report shows 640,288 shares beneficially owned indirectly, held by the Brian M. Brown Revocable Trust.
AvePoint, Inc. (AVPT) Executive Chairman and Director Gong Xunkai reported a Form 4 disclosing a routine tax-withholding share disposition related to equity vesting. On 09/12/2025 the filing shows 4,025 shares of common stock were disposed of at a price of $15.61 per share to satisfy tax withholding obligations arising from the net settlement of vested restricted stock units (RSUs). After the transaction, the reporting person beneficially owned 770,202 shares, a total that includes both non-RSU common stock and vested and unvested RSUs previously reported. The Form 4 identifies Gong Xunkai as a Director, 10% owner and Executive Chairman. The filing states the withholding was an exempt transaction under Rule 16b-3 and not a discretionary sale by the reporting person.
Jiang Tianyi, who serves as AvePoint, Inc.'s Chief Executive Officer, Director and a reported 10% owner, reported a transaction on 09/12/2025 involving the company's common stock. The filing shows 2,914 shares were disposed of at a price of $15.61 per share. The Form 4 explains this disposition was an exempt net settlement where the issuer withheld shares to satisfy income tax withholding obligations related to vested restricted stock units (RSUs).
After the transaction, the reporting person is shown as beneficially owning 556,340 shares, which combines non-RSU common stock and aggregate vested and unvested RSUs previously disclosed. The form was signed by an attorney-in-fact on 09/16/2025.
Brian Michael Brown, Chief Legal Officer and director of AvePoint, Inc. (AVPT), reported a transaction on Form 4 showing a disposition of 5,010 shares on 09/12/2025. The filing states the transaction was an exempt withholding to satisfy tax obligations in connection with the net settlement of restricted stock units (RSUs) granted under the company’s 2021 Equity Incentive Plan, at an effective price of $15.61 per share.
After the withholding, the reporting person beneficially owned 1,140,288 shares, which includes both non‑RSU common stock and aggregate vested and unvested RSUs previously reported. The filing is signed and dated 09/16/2025.
AvePoint, Inc. (AVPT) Chief Financial Officer Caci James reported a tax-withholding disposition of company shares tied to RSU vesting. The Form 4 shows a disposition of 6,120 common shares on 09/12/2025 at a price of $15.61 per share, described as withholding to satisfy income tax obligations related to net settlement of restricted stock units. After the transaction the reporting person beneficially owns 668,493 shares, which includes both non-RSU common stock and aggregate vested and unvested RSUs held under previously disclosed vesting schedules. The filing is signed by an attorney-in-fact on behalf of the reporting person.
AvePoint, Inc. entered into an underwriting agreement on September 16, 2025 to facilitate an underwritten public offering of 13,290,360 shares of its common stock, to be sold by certain selling securityholders at S$19.50 (approximately US$15.21) per share. The underwriters have a 30-day option to purchase up to an additional 1,993,550 shares. The Company applied for a secondary listing by introduction on the SGX Main Board and received a letter of eligibility; trading on SGX-ST under the symbol AVP is expected to begin September 19, 2025 following settlement of the Offering.
The Offering is a sale by selling securityholders, so AvePoint will not receive proceeds (approximately US$202 million expected to the sellers before expenses). The Company agreed to pay certain selling expenses but will not pay underwriting discounts or commissions. The filing references customary representations, indemnities, exhibits including the underwriting agreement, legal opinion, and media release.
AvePoint, Inc. is registering the resale of 13,290,360 shares of common stock by selling securityholders in connection with a secondary listing on the Singapore Exchange (SGX-ST). The company will not receive any proceeds from these sales; the selling holders are expected to receive approximately
AvePoint, Inc. is registering 13,290,360 shares of common stock for resale by selling securityholders in a secondary offering tied to a planned secondary listing on the Singapore Exchange (SGX-ST).
The company will not receive proceeds from these sales, including up to 1,993,550 additional shares subject to an over-allotment option granted by Phoenix, LLC. AvePoint’s common stock already trades on Nasdaq under “AVPT” and is expected to trade on SGX-ST under “AVP,” with a 30‑day Non‑Fungibility Period limiting transfers from SGX-ST back to Nasdaq after listing. As of June 30, 2025, 211,138,994 shares were outstanding, with 211,926,808 shares expected outstanding after the offering.
Operationally, AvePoint reported 2024 revenue of $330,482,000, up from $271,825,000 in 2023, and turned to net income of $6,459,000 for the six months ended June 30, 2025 versus a net loss in the prior‑year period. Total ARR reached $367.6 million as of June 30, 2025, with FX‑adjusted dollar‑based net retention of 112% and free cash flow of $18,286,000 for the first half of 2025, highlighting growing recurring SaaS revenues and improving profitability.
Caci James, Chief Financial Officer of AvePoint, Inc. (AVPT), reported a Section 16 Form 4 disclosing a non-discretionary share disposition on 09/05/2025. The filing shows 3,957 shares of common stock were disposed of at a price of $16.27 per share as an exempt transaction where shares were withheld to satisfy tax withholding related to the net settlement of restricted stock units (RSUs). After the withholding, the reporting person beneficially owns 667,833 shares, which includes both non-RSU common stock and aggregate vested and unvested RSUs subject to previously reported vesting schedules. The Form 4 was signed by an attorney-in-fact on 09/09/2025.
AvePoint insider transaction summary: The company reported that Brian Michael Brown, Chief Legal Officer and a director, reduced his direct holdings by 2,835 shares of common stock through an exempt withholding to satisfy tax obligations related to the net settlement of vested restricted stock units (RSUs). The transaction price per share was reported as $16.27. After the withholding, Mr. Brown is recorded as beneficially owning 1,145,298 shares, which includes both non-RSU common stock and aggregate vested and unvested RSUs previously disclosed. The filing notes the share withholding was not a discretionary sale by the reporting person but an administrative action to satisfy tax withholding and remittance obligations.